REGENERON PHARMACEUTICALSBusiness Directories,Company Directories

Company Name: Corporate Name:	REGENERON PHARMACEUTICALS
Company Title:
Company Description:
Keywords to Search:
Company Address:	777 Old Saw Mill River Road,SOUTH SALEM,NY,USA
ZIP Code: Postal Code:	10590
Telephone Number:	9143457736 (+1-914-345-7736)
Fax Number:	9143457735 (+1-914-345-7735)
Website:	axokine. net, axokine. org, genexpharma. com, ihateregeneron. com, regenaron. com, regeneron. com, regener
Email:
USA SIC Code(Standard Industrial Classification Code):	591205
USA SIC Description:	Pharmacies
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
GIBRALTAR MANAGEMENT CO.
PEQUOT CAPITAL
HUDSON OFFICE SUPPLY

Next company profile:
PEAK TECHNOLOGY
AMERICAN BOOKSELLERS ASSOCIATION
MARCEL;JOHN

Company News:

Regeneron Pharmaceuticals - Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month
Regeneron Pharmaceuticals is a leading biotech focused on gene editing While the S P 500 has dipped lower in November, Regeneron stock has climbed steadily higher Despite its recent rise
What Drugs Does Regeneron Make? A Look at Their Innovative Medicines
Discover what drugs Regeneron makes, from groundbreaking immunology treatments like Dupixent to blockbuster ophthalmology medications like Eylea Learn about their portfolio
Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent . . .
Regeneron Pharmaceuticals (REGN) shares have shown steady gains over the past month, supported by the company’s consistent revenue and net income growth Investors are keeping an eye on how
About Regeneron | Our Company - Regeneron Pharmaceuticals
Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies
PUSH THE BOUNDS OF SCIENCE - Regeneron
Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing life-transforming medicines for people with serious diseases
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an . . .
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
Is Regeneron Pharmaceuticals Stock Underperforming the S P 500?
Regeneron Pharmaceuticals has underperformed the S P 500 over the past year, but analysts are cautiously optimistic about the stock’s prospects
Regeneron Pharmaceuticals Sees Stellar Stock Surge
Regeneron has been showcasing impressive prowess in the pharma world, bolstered by an astounding Q3 earnings beat Their revenue jumped up, with notable gains from their star assets, Eylea and Dupixent